相似文献
1
The value of a systematic approach to malignant bowel obstruction.
J Support Oncol. 2008 Mar;6(3):116-7.
2
Malignant bowel obstruction: tailoring treatment to individual patients.
J Support Oncol. 2008 Mar;6(3):114-5.
3
Surgical approaches to malignant bowel obstruction.
J Support Oncol. 2008 Mar;6(3):105-13.
4
The challenge of treating malignant bowel obstruction.
J Support Oncol. 2006 Feb;4(2):83-4.
5
Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer.
J Support Oncol. 2004 Jul-Aug;2(4):323-34; discussion 334-7.
6
Intestinal obstruction.
Cancer Surv. 1994;21:147-56.
7
How to use octreotide for malignant bowel obstruction.
J Support Oncol. 2004 Jul-Aug;2(4):357-64.
8
The role of octreotide in malignant bowel obstruction.
Oncol Nurs Forum. 1999 Jun;26(5):831-2.
9
[Malignant bowel obstruction].
Med Clin (Barc). 2010 Sep 11;135(8):375-81. doi: 10.1016/j.medcli.2010.03.002. Epub 2010 May 8.
10
Aggressive pharmacological treatment for reversing malignant bowel obstruction.
J Pain Symptom Manage. 2004 Oct;28(4):412-6. doi: 10.1016/j.jpainsymman.2004.01.007.
引用本文的文献
1
Palliative surgery versus medical management for bowel obstruction in ovarian cancer.
Cochrane Database Syst Rev. 2010 Jul 7;2010(7):CD007792. doi: 10.1002/14651858.CD007792.pub2.
Zotero 插件